Shao-Liang Chen -PADN-5: Pulmonary arterial denervation in patients with pulmonary hypertension associated with left heart failure (NCT02220335)

Shao-Liang Chen, Nanjing First Hospital, Nanjing Medical University, China
PADN-5: Pulmonary arterial denervation in patients with pulmonary hypertension associated with left heart failure (NCT02220335)
Sponsor: Nanjing Healthy Bureau & National Science Foundation of China

About the author

Shao-Liang Chen

MD, PhD

Nanjing First Hospital, Nanjing Medical University

China

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

About the author

Shao-Liang Chen

Related Content

{{GlobalController.truncateTitle("Mitochondrial genes and PAH", 65)}}

{{GlobalController.truncateTitle("Connection between COVID-19 and pulmonary vascular disease ", 65)}}

{{GlobalController.truncateTitle("Keynote lecture session 2021", 65)}}

{{GlobalController.truncateTitle("John Scandurra & Irene Lang - Implantable devices to improve pulmonary circulation compliance", 65)}}

{{GlobalController.truncateTitle("Kelly Chin - Efﬁcacy and safety of initial triple oral versus initial double oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: Results of the randomised controlled TRITON study (NCT02558231)", 65)}}

Add to reading list

Share this content

Our research platform is the world.